Zomedica appoints Sean Whelan to Board; Wolfenberg resigns as director

Zomedica Corp.

Christopher Wolfenberg resigned from Zomedica Board effective Sept. 13, 2021, not due to any disagreement.
Sean Whelan appointed to fill vacancy; will chair Audit Committee.
Whelan is CEO of Encore Rehabilitation Services, former CFO of Diplomat and InfuSystem, and a CPA.
Whelan received options for 800,000 common shares at $0.57/share, vesting over 4 years.
The board change took effect immediately on September 13, 2021.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sean Whelan

member of the Board of Directors

ZOMDF · Zomedica Corp.

Effective: 2021-09-13
Filed: September 13, 2021, 7:59 PM ET

On September 13, 2021, the Board appointed Sean Whelan as a member of the Board to fill the vacancy created by Mr. Wolfenberg’s resignation.

Departed

Christopher Wolfenberg

member of the Board of Directors

ZOMDF · Zomedica Corp.

Effective: 2021-09-13
Successor: Sean Whelan
Filed: September 13, 2021, 7:59 PM ET

On September 13, 2021, Christopher Wolfenberg resigned, effective immediately, as a member of the Board of Directors (the “Board”) of Zomedica Corp. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sean Whelan was appointed as member of the Board of Directors at Zomedica Corp..

Action: appointed
Role: member of the Board of Directors

Exact text from the filing

On September 13, 2021, the Board appointed Sean Whelan as a member of the Board to fill the vacancy created by Mr. Wolfenberg’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Wolfenberg resigned as member of the Board of Directors at Zomedica Corp..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On September 13, 2021, Christopher Wolfenberg resigned, effective immediately, as a member of the Board of Directors (the “Board”) of Zomedica Corp. (the “Company”).

View on SEC.gov

Zomedica Corp. filing history →

Source: SEC EDGAR

accession 0001171843-21-006450

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.